Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Levy

Showing results (1181-1190 of 1,183) with videos related to

Pageof 119
Sort By:
You have reached the last page of results.This site can display upto 1,183 results.
Journal of Cardiac Failure|January 4, 2026
Mean Arterial Pressure and Mortality in Infarction-Related Cardiogenic Shock with and without Cardiac Arrest: A Meta-AnalysisS Ten Berg, M Bogerd, E J Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.
Genome Biology|May 13, 2009
Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescensMark W Silby, Ana M Cerdeño-Tárraga, Georgios S Vernikos, et al.
Pageof 119

Showing results (1181-1190 of 1,183) with videos related to

Sort By:
Pageof 119
You have reached the last page of results.This site can display upto 1,183 results.
Journal of Cardiac Failure|January 4, 2026
Mean Arterial Pressure and Mortality in Infarction-Related Cardiogenic Shock with and without Cardiac Arrest: A Meta-AnalysisS Ten Berg, M Bogerd, E J Peters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.
Genome Biology|May 13, 2009
Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescensMark W Silby, Ana M Cerdeño-Tárraga, Georgios S Vernikos, et al.
Pageof 119